Rac1 is a novel therapeutic target in mantle cell lymphoma.

about

Rac1 is a novel therapeutic target in mantle cell lymphoma.

Item

http://www.wikidata.org/entity/Q49659048

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Rac1 is a novel therapeutic target in mantle cell lymphoma.

@en

Rac1 is a novel therapeutic target in mantle cell lymphoma.

@nl

type

Item

label

Rac1 is a novel therapeutic target in mantle cell lymphoma.

@en

Rac1 is a novel therapeutic target in mantle cell lymphoma.

@nl

prefLabel

Rac1 is a novel therapeutic target in mantle cell lymphoma.

@en

Rac1 is a novel therapeutic target in mantle cell lymphoma.

@nl

P1476

Rac1 is a novel therapeutic target in mantle cell lymphoma.

@en

P2093

Ashley L Hein

http://www.w3.org/2001/XMLSchema#string

Charles Enke

http://www.w3.org/2001/XMLSchema#string

Cheng Wang

http://www.w3.org/2001/XMLSchema#string

Chengfeng Bi

http://www.w3.org/2001/XMLSchema#string

Ji Yuan

http://www.w3.org/2001/XMLSchema#string

Kai Fu

http://www.w3.org/2001/XMLSchema#string

Songfei Shen

http://www.w3.org/2001/XMLSchema#string

Tian Tian

http://www.w3.org/2001/XMLSchema#string

Timothy C Greiner

http://www.w3.org/2001/XMLSchema#string

Xuan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.

Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB

Rational design and characterization of a Rac GTPase-specific small molecule inhibitor

Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas

8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma.

Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era

Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemia.

Rac1 GTPase: a "Rac" of all trades.

Novel agents in mantle cell lymphoma.

P2888

s41408-018-0052-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41408-018-0052-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Julie M Vose

P577

2018-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100983449

http://www.w3.org/2001/XMLSchema#string

P698

29434202

http://www.w3.org/2001/XMLSchema#string

P932

5809391

http://www.w3.org/2001/XMLSchema#string